|
Re: any tumor tests to predict which chemos work better?
Greg,
I sent the information that you have been so kindly providing Sarah and asked if we could consider chemo sensitivity testing and this is his response, "ASCO, the group that supervises breast cancer care in the US and world has looked at these chemosensitivity studies. Their recommendation is that they don’t work and per their April 2011 Guideline Update, they specifically recommend not running them. We can talk and still try to run it on a fresh biopsy if you want, and if your insurance co agrees to pay for the test. "
I read the 2011 Guidelines and it stated there have not been enough studies conducted to consider these viable tests.
I hope things change soon so we don't have to continue with the shotgun method of choosing a treatment.
Thank you for all you do to provide us with valuable information.
Emelie
__________________
Nov. 2006-IDC with Her2 +++
A/C for 3 rounds
Dec. 2006- Herceptin and Taxotere
March 2007-MRM with 8 of 14 lymph node involvement
May 2007-36 Rads
Sept. 2007- Stopped Herceptin
Jan. 2010- CT scan shows enlarged lymph nodes in sternum and lung involvement
Feb. 2010-PET scan shows mets to liver, lung, lymph nodes and bone
Feb. 2010- Started Herceptin/Taxol and Zometa
April 2010-PET scan clear. Herceptin and Zometa
June 2010- Stopped Herceptin continue Zometa and still NED
August 2010-Back on Herceptin and Zometa every 3 weeks
August 13, 2010- Had another port placed
August 24, 2010- PET scan clear. Herceptin and Zometa every three weeks
Nov. 2010-PET scan clear
Feb. 2011-Brain MRI clear
March 2011- PET scan clear
May 2011- PET scan clear
Sept. 2011- PET, Mammo, Bone Scan all clear- Herceptin only
March 2012-Recurrence in lungs and tumor around pota hepatis artery. Added Navelbine to herceptin
April 2012- Entered palliative care
June 5, 2012-Entered hospice care
Planning my memorial
|